Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
3.690
+0.005 (0.14%)
At close: Jun 27, 2025, 4:00 PM
3.700
+0.010 (0.27%)
After-hours: Jun 27, 2025, 7:23 PM EDT
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $882.85 million as of June 27, 2025. Its market cap has decreased by -41.59% in one year.
Market Cap
882.85M
Enterprise Value
850.53M
1-Year Change
-41.59%
Ranking
Category
Stock Price
$3.69
Market Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $882.85M, an increase of 263.76%. That is a compound annual growth rate of 12.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 881.70M | -26.58% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 216.45B |